头颈显微重建术后气道控制中长期地塞米松方案的安全指数:考虑体表面积
该回顾性研究纳入156例头颈癌显微游离皮瓣重建并鼻气管插管患者,其中139例接受长期地塞米松(>2天)治疗。研究定义安全指数为地塞米松总量(mg)分别除以体重、BMI和体表面积(BSA),发现BSA组安全指数界值为33.84 mg/m²,且在多变量分析中为皮瓣感染的唯一独立危险因素(OR=6.242,95%CI 2.292-17.002,P=0.000)。
要点
- 长期地塞米松(>2天)用于头颈显微重建术后气道控制时,需关注皮瓣感染风险。
- 基于体表面积的安全指数界值为33.84 mg/m²,超过此值感染风险增加。
- BSA安全指数是皮瓣感染的唯一独立危险因素(OR=6.242)。
核心结论
- 安全指数(尤其基于体表面积)有助于预测头颈显微重建术后使用地塞米松控制气道时的皮瓣感染风险。
主要发现
- 安全指数界值:体重组0.76,BMI组2.28(10⁻³ m²),BSA组33.84 mg/m²。
- 多变量分析中BSA组安全指数为皮瓣感染的唯一独立危险因素(OR=6.242,95%CI 2.292-17.002,P=0.000)。
关键数值与推荐
- BSA组安全指数界值为33.84 mg/m²,超过此值皮瓣感染风险增加。
临床怎么用
- 临床可使用基于体表面积的安全指数(地塞米松总剂量/BSA)评估长期地塞米松治疗时的皮瓣感染风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dexamethasone (Dexa) is frequently administrated to patients receiving head and neck microsurgical reconstruction with nasotracheal intubation postoperatively for airway control. Infection is the greatest concern when prolonging the treatment course. We aimed to find out the relationship between flap infection and the safe dose of Dexa. MATERIALS AND METHODS: A retrospective review of enrolling total 156 patients underwent microsurgical free flap reconstruction for head and neck cancers with nasotracheal intubation from December 2015 to December 2016 was conducted. Among them, 139 patients had received prolonged Dexa treatment course (>2 days). Safe index was then defined as the total amount of used Dexa (in milligrams) over body weight (in kilograms), body mass index (in kilograms per square meter) and body surface area (BSA, in square meter). Statistics were performed for the cutoff level of the safe index and to find out the independent risk factors. RESULTS: The cutoff level of the safe index was 0.76 for body weight group, 2.28 (10-3 m2) for body mass index group, and 33.84 mg/m2 for BSA group. Safe index for BSA group also outweighed other risk factors in multivariant analysis (odds ratio = 6.242, 95% confidence interval = 2.292-17.002, P = 0.000), which is the only independent risk factors for flap infection in our cohort. CONCLUSIONS: Throughout our study, the "safe index" helps clinician easily predict flap infection risk when using Dexa as the medication for airway control after head and neck microsurgical reconstruction.
引用
- Chen YT, Cheong DC, Hung SY, et al. The "Safe Index" Considering Body Surface Area for Prolonged Dexamethasone Regimen in Airway Control After Head and Neck Microsurgical Reconstruction. Ann Plast Surg. 2021. PMID: 33438957. doi:10.1097/SAP.0000000000002660
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。